A deep spatial proteomic analysis of healthy fallopian tube epithelium, matching high-grade serous ovarian cancer (HGSOC) ...

AI-based drug developer Recursion’s stock barely moved Wednesday, then dropped Thursday and Friday, after reporting mixed third quarter results, setting the stage for future pipeline announcements—and ...

High CD8-positive T cell infiltration is linked to shorter PFS in epithelial ovarian cancer patients treated with bevacizumab ...

Scientists at The Wistar Institute have solved a longstanding puzzle in ovarian cancer treatment: why anti-estrogen therapy often fails even when tumors express the hormone receptor that should make ...

Artificial intelligence (AI) is set to transform the care of women with cancer. From early detection via digital phenotyping ...

Chromosome compartment analysis of a cancer cell line cohort reveals different subsets of compartment changes where some track epithelial to mesenchymal transition while others reflect secondary ...

Results of a study led by researchers at Roswell Park Comprehensive Cancer Center show that combining two types of immunotherapy - engineered T cells that secrete bispecific T cell engagers (BiTEs) ...

CLEO Diagnostics Ltd ( (AU:COV)) has provided an update. Cleo Diagnostics Ltd has identified a significantly larger Total Addressable Market for its Pre-Surgical Ovarian Cancer Test in the U.S., with ...

Nurse-led telehealth follow-ups may increase emotional well-being for survivors of ovarian cancer, according to data from a ...

Biomarker testing for patients with ovarian cancer should be completed both in the upfront setting and through disease ...